Ignite Creation Date:
2025-12-26 @ 11:13 PM
Ignite Modification Date:
2026-03-16 @ 10:18 PM
Study NCT ID:
NCT00706212
Status:
UNKNOWN
Last Update Posted:
2008-06-27
First Post:
2008-06-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Accuracy of CHOLINE PET CT in the Diagnosis of Urological Malignancies
Sponsor:
Rabin Medical Center
Organization:
Study Overview
Official Title:
A Comparative Study to Examine the Accuracy of CHOLINE PET CT in the Diagnosis
Status:
UNKNOWN
Status Verified Date:
2008-05
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
GS-PET-2008
Brief Summary:
PET CT is one of the imaging tools that are used for staging of urological malignancies.
C11 Choline is a novel isotope with the advantage of its minimal secretion in the urine. This advantage makes it a potentially better metabolic marker then others such as FDG. Preliminary studies showed \~95% sensitivity in the diagnosis of TCC. Our Goal is to continue the evaluation of this method as a diagnostic and follow up tool in different urological malignancies.
C11 Choline is a novel isotope with the advantage of its minimal secretion in the urine. This advantage makes it a potentially better metabolic marker then others such as FDG. Preliminary studies showed \~95% sensitivity in the diagnosis of TCC. Our Goal is to continue the evaluation of this method as a diagnostic and follow up tool in different urological malignancies.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: